Institute for Translational Medicine and Therapeutics, Department of Pharmacology, University of Pennsylvania School of Medicine, USA; Institute for Translational Medicine and Therapeutics, University of Pennsylvania, USA.
Department of Pediatrics, The Children's Hospital of Philadelphia, USA; Institute for Translational Medicine and Therapeutics, University of Pennsylvania, USA.
Biomaterials. 2014 Apr;35(11):3708-15. doi: 10.1016/j.biomaterials.2014.01.023. Epub 2014 Jan 27.
Endothelial-targeted delivery of antioxidant enzymes, catalase and superoxide dismutase (SOD), is a promising strategy for protecting organs and tissues from inflammation and oxidative stress. Here we describe Protective Antioxidant Carriers for Endothelial Targeting (PACkET), the first carriers capable of targeted endothelial delivery of both catalase and SOD. PACkET formed through controlled precipitation loaded ~30% enzyme and protected it from proteolytic degradation, whereas attachment of PECAM monoclonal antibodies to surface of the enzyme-loaded carriers, achieved without adversely affecting their stability and functionality, provided targeting. Isotope tracing and microscopy showed that PACkET exhibited specific endothelial binding and internalization in vitro. Endothelial targeting of PACkET was validated in vivo by specific (vs IgG-control) accumulation in the pulmonary vasculature after intravenous injection achieving 33% of injected dose at 30 min. Catalase loaded PACkET protects endothelial cells from killing by H2O2 and alleviated the pulmonary edema and leukocyte infiltration in mouse model of endotoxin-induced lung injury, whereas SOD-loaded PACkET mitigated cytokine-induced endothelial pro-inflammatory activation and endotoxin-induced lung inflammation. These studies indicate that PACkET offers a modular approach for vascular targeting of therapeutic enzymes.
内皮靶向递送抗氧化酶,如过氧化氢酶和超氧化物歧化酶(SOD),是一种有前途的策略,可以保护器官和组织免受炎症和氧化应激的影响。在这里,我们描述了保护性抗氧化载体用于内皮靶向(PACkET),这是第一种能够靶向内皮细胞递送过氧化氢酶和 SOD 的载体。PACkET 通过控制沉淀形成,负载了约 30%的酶,并保护其免受蛋白水解降解,而将 PECAM 单克隆抗体附着在酶负载载体的表面上,在不影响其稳定性和功能的情况下实现了靶向作用。同位素示踪和显微镜观察表明,PACkET 在体外具有特异性的内皮结合和内化作用。体内研究通过静脉注射后特异性(与 IgG 对照)在肺血管中的积累得到了验证,在 30 分钟时达到了 33%的注射剂量。负载过氧化氢酶的 PACkET 可保护内皮细胞免受 H2O2 的杀伤,并减轻内毒素诱导的肺损伤小鼠模型中的肺水肿和白细胞浸润,而负载 SOD 的 PACkET 则减轻了细胞因子诱导的内皮促炎激活和内毒素诱导的肺炎症。这些研究表明,PACkET 为治疗性酶的血管靶向提供了一种模块化方法。